1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Non-Invasive Prenatal Testing Market
2.2. Global Non-Invasive Prenatal Testing Market, By Products, 2023 (US$ Million)
2.3. Global Non-Invasive Prenatal Testing Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Non-Invasive Prenatal Testing Market: Competitive Analysis
3.1. Market Positioning of Key Non-Invasive Prenatal Testing Market Vendors
3.2. Strategies Adopted by Non-Invasive Prenatal Testing Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Non-Invasive Prenatal Testing Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Non-Invasive Prenatal Testing Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. MaterniT21 PLUS
5.3.2. BambniTest
5.3.3. informaSeq Prenatal Test
5.3.4. Harmony Prenatal Test
5.3.5. Non-invasive Fetal Trisomy (NIFTY) Test
5.3.6. verifi
5.3.7. PrenaTest
5.3.8. Panorama Test
5.3.9. VisibiliT Test


6. North America Non-Invasive Prenatal Testing Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
6.3.Non-Invasive Prenatal Testing Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)

7. UK and European Union Non-Invasive Prenatal Testing Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
7.3.Non-Invasive Prenatal Testing Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)

8. Asia Pacific Non-Invasive Prenatal Testing Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
8.3.Non-Invasive Prenatal Testing Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)

9. Latin America Non-Invasive Prenatal Testing Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
9.3.Non-Invasive Prenatal Testing Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)

10. Middle East and Africa Non-Invasive Prenatal Testing Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
10.3.Non-Invasive Prenatal Testing Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Non-Invasive Prenatal Testing Market: By Products, 2022-2032, USD (Million)

11. Company Profile
11.1. Ariosa Diagnostics, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Berry Genomics Co., Ltd.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. BGI Diagnostics
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Illumina, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Laboratory Corporation of America Holdings (LabCorp)
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. LifeCodexx AG
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Natera, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Sequenom, Inc.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Others
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives